Home Featured Page 228

Featured

Latest

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

More Details on the Psilocybin Mushroom Bluing Reaction

Why Don’t Magic Mushroom Spores Contain Psilocybin?

Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain

Is Nitrous Oxide a Psychedelic Drug?

Keeping Participants Safe in Psychedelic Research

MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD...

atai Launches Revixia Life Sciences to Develop Salvinorin A for a...

Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under...

Psychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin...

Cybin Announces Additional Adelia Milestone Achievements

1...227228229...299 Page 228 of 299

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club – Trip Sitting

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

More Details on the Psilocybin Mushroom Bluing Reaction

Why Don’t Magic Mushroom Spores Contain Psilocybin?

Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain

Is Nitrous Oxide a Psychedelic Drug?

Keeping Participants Safe in Psychedelic Research

MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD...

atai Launches Revixia Life Sciences to Develop Salvinorin A for a...

Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under...

Psychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin...

Cybin Announces Additional Adelia Milestone Achievements

EDITOR PICKS

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY